Ephrin type-A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3-kinase/Akt signalling pathway. The gene discussed is EPHA2; the disease is nasopharyngeal carcinoma.